Following his arrest, Shkreli took to Twitter to say the fraud allegations against him were “baseless and without merit”.
Advertisement
Shkreli – known for his blustery personality – tweeted Saturday that he will triumph.
As we reported previously, Martin Shkreli is the 32-year old executive notorious for topping up the price of an HIV-related drug by 5,000%.
A spokesman for Shkreli says he denies the securities fraud charges he’s facing and “expects to be fully vindicated”.
Shkreli was already widely reviled because a drug company he founded raised the price of a life-saving drug from $US13.50 to $US750 per pill.
Other posts mocked Shkreli for his infamous price-gouging and his boasts about buying a one-of-a-kind Wu-Tang Clan album for $2 million.
“We remain committed to ensuring that all patients have ready and affordable access to Daraprim”, he said.
Combative, often crass and willfully sophomoric, Shkreli has – so far – appeared to revel in being described as a “pharma bro”, the “drug industry’s villain” and far more unprintable terms since his Turing Pharmaceuticals jacked up the price of Daraprim.
The move – and Shkreli’s arrogant response to the controversy – was angrily denounced by USA politicians, including Democratic presidential contender Hillary Clinton.
Critics labelled Shkreli a “putz” and a “psychopath”, while his actions earned him the nickname “Pharmo Bro”.
One of the tweets said: “Anyone want free money?”
“Thanks for your support”, Shkreli told some 800 viewers on the Youtube broadcast.
Advertisement
During this adjustment after Shkreli’s arrest, that same company was forced to hold a meeting to announce the cutting of earnings and sales forecasts, as reported by The New York Times.
